KIF20B Promotes Cell Proliferation and May Be a Potential Therapeutic Target in Pancreatic Cancer-Reference-Cited by-同舟云学术

KIF20B Promotes Cell Proliferation and May Be a Potential Therapeutic Target in Pancreatic Cancer

Published:2021-09-09 Issue: Volume:2021 Page:1-11
ISSN:1687-8469
Container-title:Journal of Oncology
language:en
Short-container-title:Journal of Oncology

Author:

Chen Jing¹,Zhao Cui-Cui²,Chen Fei-Ran³,Feng Guo-Wei³,Luo Fei⁴,Jiang Tao⁵^ORCID

Affiliation:

1. Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, No. 24, Binshui Street, Hexi District, Tianjin 300060, China

2. Department of VIP Ward, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, No. 24, Binshui Street, Hexi District, Tianjin 300060, China

3. Department of Genitourinary Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, No. 24, Binshui Street, Hexi District, Tianjin 300060, China

4. Department of Urology, Tianjin People’s Hospital, No. 190, Jieyuan Road, Hongqiao District, Tianjin 300121, China

5. Department of General Surgery, Dongzhimen Hospital, Beijing University of Chinese Medicine, No. 5 Haiyuncang, Dongcheng District, Beijing 100700, China

Abstract

KIFs have been reported to play a critical role in a variety of tumors, and KIF20B is a protein in KFIs. In this research, KIF20B was highly expressed in the GEO database and our hospital’s data, and high expression of KIF20B suggested poor prognosis. We detect the expression of KIF20B in pancreatic cancer and adjacent normal tissues using immunohistochemistry. Knockdown of KIF20B in pancreatic cancer cell lines, PANC-1 and BxPC-3 cells, inhibited cell proliferation which are detected by colony formation assays, CCK8, and western bolt of Ki-67 and PCNA. Xenograft assay showed a similar result in vivo. KIF20B is a potential therapeutic target in pancreatic cancer.

Funder

National Natural Science Foundation of China

Publisher

Hindawi Limited

Subject

Oncology

Link

http://downloads.hindawi.com/journals/jo/2021/5572402.pdf

Reference40 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Addressing the challenges of pancreatic cancer: Future directions for improving outcomes

3. Pancreatic cancer

4. Cancer statistics, 2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring KRAS-mutant pancreatic ductal adenocarcinoma: a model validation study;Frontiers in Immunology;2024-01-10

2. Proteomic signature for detection of high‐grade ovarian cancer in germline BRCA mutation carriers;International Journal of Cancer;2022-10-23

3. Integrating cell cycle score for precise risk stratification in ovarian cancer;Frontiers in Genetics;2022-08-17

4. Construction of a Novel Prognostic Model in Lung Adenocarcinoma Based on 7-Methylguanosine-Related Gene Signatures;Frontiers in Oncology;2022-06-16